Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hisaaki Chaki"'
Autor:
Tetsuya Yamamoto, Kimiko Morimoto, Hisaaki Chaki, Shuichi Hirono, Akira Hashiramoto, Hirokazu Narita, Yukihiko Aikawa, Shunichi Shiozawa
Publikováno v:
Nature Biotechnology. 26:817-823
To inhibit arthritis upstream of inflammatory cytokine release and matrix metalloproteinase (MMP) action, we designed de novo a small-molecule inhibitor of c-Fos/activator protein-1 (AP-1) using three-dimensional (3D) pharmacophore modeling. This mod
Autor:
Yukihiko Aikawa, Tadakazu Takakura, Keiichi Tsuchida, Shuichi Hirono, Hisaaki Chaki, Hiroaki Gouda, Shunichi Shiozawa, Junichi Yokotani
Publikováno v:
Journal of Medicinal Chemistry. 47:4239-4246
The transcription factor activator protein-1 (AP-1) is an attractive target for the treatment of immunoinflammatory diseases, such as rheumatoid arthritis. Using the three-dimensional (3D) X-ray crystallographic structure of the DNA-bound basic regio
Autor:
Hisaaki Chaki, Yozo Todo, Hirokazu Narita, Tetsuo Yamafuji, Kazunori Kitamura, Masaru Tai, Hajime Morita, Mutsuko Maekawa, Naomi Okada, Satoshi Ono
Publikováno v:
Chemical and Pharmaceutical Bulletin. 43:1492-1496
2-(2-Aminoethoxy)-1-hydroxyethyl derivatives of bicyclic arenes (naphthalene, thianaphthene, benzofuran, and indole) were prepared and screened for antiamnestic (AA) and antihypoxic (AH) activities which were evaluated by measuring the reversing pote
Autor:
Tadakazu Takakura, Hisaaki Chaki, Hironori Kotsubo, Shunichi Shiozawa, Tadashi Tanaka, Yukihiko Aikawa, Shuichi Hirono, Keiichi Tsuchida
Publikováno v:
Journal of medicinal chemistry. 49(1)
We designed and synthesized small-molecule activator protein-1 (AP-1) inhibitors based on a three-dimensional (3D) pharmacophore model that we had previously derived from a cyclic decapeptide exhibiting AP-1 inhibitory activity. New AP-1 inhibitors w
Autor:
Keiichi, Tsuchida, Hisaaki, Chaki, Tadakazu, Takakura, Junichi, Yokotani, Yukihiko, Aikawa, Shunichi, Shiozawa, Hiroaki, Gouda, Shuichi, Hirono
Publikováno v:
Journal of medicinal chemistry. 47(17)
The transcription factor activator protein-1 (AP-1) is an attractive target for the treatment of immunoinflammatory diseases, such as rheumatoid arthritis. Using the three-dimensional (3D) X-ray crystallographic structure of the DNA-bound basic regio
Autor:
Kuniko Mozumi, Hisaaki Chaki, Kazunori Kitamura, Yasushi Nakada, Tetsuo Yamafuji, Tatsuo Kimura, Mutsuko Maekawa, Satoshi Ono, Hirokazu Narita, Yozo Todo
Publikováno v:
Biologicalpharmaceutical bulletin. 18(12)
The title compound (T-588) has been evaluated for its ameliorating effect on memory impairment generated by cerebral embolization and by a basal forebrain (BF) lesion in male Wistar rats. The memory and learning deficits induced by injection of carbo
Autor:
Masaru Tai, Hisaaki Chaki, Tetsuo Yamafuji, Mutsuko Maekawa, Satoshi Ono, Hirokazu Narita, Yozo Todo, Kazunori Kitamura
Publikováno v:
Chemicalpharmaceutical bulletin. 43(9)
N-(2-Dimethylaminoethyl)carboxamide (1a-d), 2-dimethylaminoethyl alkyl ether (2a, b), and 2-dimethylaminoethyl 2-hydroxy-2-phenethyl ether (3a-c) and its amino and methylene analogues (3d, 4) have been screened for antiamnestic and antihypoxic activi
Autor:
Yozo Todo, Masaru Tai, Mutsuko Maekawa, Hirokazu Narita, Satoshi Ono, Hajime Morita, Tetsuo Yamafuji, Kazunori Kitamura, Hisaaki Chaki
Publikováno v:
Chemicalpharmaceutical bulletin. 43(9)
A series of 2-(2-aminoethoxy)-1-phenylethanols having a variety of N- and phenyl-substitution patterns as well as 5- and 6-membered heteroaryl counterparts of our prototype compound 1 (2-(2-dimethylaminoethoxy)-1-phenylethanol) have been prepared and
Publikováno v:
Chemical and Pharmaceutical Bulletin. 32:1232-1235
Riboflavin undergoes a characteristic biphasic photolysis with a low-intensity light source, depending on the ionic strength of the phosphate buffer used. In higher ionic strength phosphate buffer, an initial faster phase is followed by a slower seco
Publikováno v:
Annals of the New York Academy of Sciences. 471:316-317